ABSTRACT
OBJECTIVE: The aim was to evaluate the effectiveness and safety of PlasmaJet™ in cytoreductive surgery in patients with advanced-stage ovarian cancer. METHODS: All patients between September 2013 and January 2018 undergoing surgical cytoreduction for advanced-stage ovarian cancer with the help of PlasmaJet™ were identified and analyzed retrospectively. RESULTS: Eighty-seven patients diagnosed with advanced-stage ovarian cancer underwent surgery with PlasmaJet™. Primary debulking surgery was performed in 15 cases. Fifty-seven patients underwent interval debulking after neoadjuvant chemotherapy. Secondary and tertiary debulking was done in, respectively, 11 and three patients, and one patient underwent quaternary debulking using PlasmaJet™. In all 87 patients but one, complete resection of all macroscopic disease was obtained. PlasmaJet™ was used to remove carcinomatosis on the peritoneum, bowel serosa, intestinal mesentery, and lesions in the upper abdomen (diaphragm and liver surface). No damage to the bladder or ureter was noted in relation to the use of PlasmaJet™. Three patients developed a bowel leakage postoperatively. In one of these patients, PlasmaJet™ was used to treat tumoral implants in the affected region. CONCLUSIONS: Our series suggests that the use of PlasmaJet™ is efficient and safe in obtaining complete resection of all macroscopic tumoral lesions in advanced-stage ovarian cancer.
Subject(s)
Argon Plasma Coagulation/instrumentation , Cytoreduction Surgical Procedures/methods , Neoadjuvant Therapy/methods , Ovarian Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Middle Aged , Neoplasm Staging , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/pathology , Retrospective Studies , Survival Rate , Treatment Outcome , Young AdultABSTRACT
PURPOSE: This study aims to compare the effects and prognosis of medical thoracoscopy-assisted argon plasma coagulation (APC) combined with electrosurgical unit (ESU) surgery, video-assisted thoracic surgery (VATS), and pleurodesis surgery, in providing appropriate treatment for elderly refractory pneumothorax patients. METHODS: Patients with refractory pneumothorax aged over 65 years were divided into three groups: APC combined with ESU (N = 20), VATS (N = 26), and pleurodesis (N = 24). Data on demographic characteristics, lung function evaluation, and short- and long-term prognoses were collected. RESULTS: Following surgery, compared with the APC-ESU and pleurodesis groups, patients in the VATS group demonstrated poor short-term prognoses, with high pleural effusion drainage levels and high visual analog scores (VAS; P <0.05). After the surgery, St. George's Respiratory Questionnaire (SGRQ) scores in the pleurodesis group were slightly elevated, whereas SGRQ scores in both the APC-ESU and VATS groups demonstrated a continual decrease. Finally, medical resource consumption analysis demonstrated a significant difference in hospitalization costs among the three groups; the VATS group being the most expensive. CONCLUSION: Medical thoracoscopy-assisted APC combined with ESU is a safe, effective, and affordable treatment for elderly patients with refractory pneumothorax.
Subject(s)
Argon Plasma Coagulation/instrumentation , Electrosurgery/instrumentation , Pleurodesis , Pneumothorax/surgery , Thoracic Surgery, Video-Assisted , Thoracoscopy/instrumentation , Aged , Aged, 80 and over , Argon Plasma Coagulation/adverse effects , Argon Plasma Coagulation/economics , Cost-Benefit Analysis , Electrosurgery/adverse effects , Electrosurgery/economics , Female , Hospital Costs , Humans , Male , Non-Randomized Controlled Trials as Topic , Pleurodesis/adverse effects , Pneumothorax/diagnostic imaging , Pneumothorax/economics , Postoperative Complications/etiology , Risk Factors , Thoracic Surgery, Video-Assisted/adverse effects , Thoracoscopy/adverse effects , Thoracoscopy/economics , Time Factors , Treatment OutcomeABSTRACT
BACKGROUND: Abdominoplasty is one of the most common procedures in plastic surgery, and energy-based tissue dissection techniques have become the gold standard. Despite its frequency, abdominoplasty is still associated with high complication rates. OBJECTIVES: The authors compared clinical and economic data of 4 methods of energy-based tissue dissection in a randomized, open-label study. METHODS: A total of 57 patients were preoperatively randomized into 4 groups: electrocautery, Ultracision Harmonic Scalpel, argon plasma coagulation, and PEAK-Plasmablade. Demographic and operational data as well as information on the postoperative course and complications were collected. For economic analysis, quotes were obtained from the device companies or official suppliers. RESULTS: Duration of surgery, drainage quantity, and wound healing complications did not differ significantly between groups. The Ultracision method caused significantly greater blood loss compared with all other techniques (P < 0.01). PEAK and Ultracision devices entailed greater surgical costs compared with APC and electrocautery. CONCLUSIONS: All methods evaluated can be applied safely and effectively in abdominoplasty procedures. However, these data demonstrate a significantly higher blood loss for the Ultracision Harmonic Scalpel. Considering the clinical data, the higher costs of PEAK and Ultracision methods appear unjustified.
Subject(s)
Abdominoplasty/economics , Abdominoplasty/methods , Dissection/economics , Dissection/instrumentation , Adult , Argon Plasma Coagulation/economics , Argon Plasma Coagulation/instrumentation , Blood Loss, Surgical , Electrocoagulation/economics , Electrocoagulation/instrumentation , Equipment Design , Female , Humans , Male , Middle Aged , Surgical Instruments/economicsSubject(s)
Argon Plasma Coagulation/methods , Gastrointestinal Hemorrhage/therapy , Jejunum , Argon Plasma Coagulation/instrumentation , Endoscopy, Gastrointestinal , Female , Gastrointestinal Hemorrhage/diagnostic imaging , Gastrointestinal Hemorrhage/etiology , Humans , Jejunum/blood supply , Jejunum/diagnostic imaging , Middle Aged , Tomography, X-Ray Computed , Treatment OutcomeABSTRACT
No disponible
Subject(s)
Humans , Female , Adult , Lymphangioma/pathology , Lymphangioma , Hemorrhage/complications , Hemorrhage/etiology , Gastroscopy/instrumentation , Colonoscopy/methods , Colonoscopy , Blood Coagulation/radiation effects , Argon Plasma Coagulation/instrumentation , Argon Plasma Coagulation/methods , Double-Balloon Enteroscopy/instrumentation , Argon Plasma Coagulation/standards , Argon Plasma Coagulation/trends , Gastroscopy/methodsABSTRACT
BACKGROUND AND AIMS: Pulmonary hamartomas appear as parenchymal or endobronchial lesions, the latter representing '1.4 to 11%' of the total number of pulmonary hamartomas. Endobronchial hamartomas usually emerge as a single mass. As they are accepted as benign tumors, endobronchial treatments are recommended today. 45 year-old male patient admitted with cough, phlegm and fever. A lesion totally obstructing the right main bronchus was found in CT. METHODS: In his brochoscopy, a mobile, smooth-surfaced lesion obstructing right main bronchus was seen. Its histopathology was reported as 'hamartoma.' RESULTS: The lesion was removed by using argon plasma coagulation and electrocotery. After the removal of the lesion in right main bronchus, another lesion with similar characteristics was seen in the intermedius bronchus and this lesion which histopathology was reported as 'hamartoma' was excised by using electrocauter snare. There was no recurrence in the 24 month follow-up. CONCLUSION: Reports of multiple endobronchial hamartomas are rare in the literature, and the awareness of this form of benign disease is important in the differential diagnosis of pulmonary diseases.
Subject(s)
Bronchial Diseases/diagnosis , Bronchial Diseases/therapy , Hamartoma/diagnosis , Hamartoma/therapy , Argon Plasma Coagulation/instrumentation , Bronchoscopy , Combined Modality Therapy , Diagnosis, Differential , Humans , Male , Middle Aged , Tomography, X-Ray Computed/methods , Treatment OutcomeABSTRACT
OBJECTIVES: Complete cytoreduction of ovarian cancer often requires excision or ablation of bowel serosa implants. Both argon beam coagulator (ABC) and thermal plasma energy (TPE) (PlasmaJet; PlasmaSurgical, Roswell, Ga) have been used to ablate bowel serosa implants. Our objective was to identify comparable power settings as well as determine the rate of bowel perforation, depth of thermal injury, and extent of inflammatory response with ABC versus TPE in a porcine model. MATERIALS AND METHODS: Nine pigs underwent vaporization of small bowel and colon serosa according to assigned treatment group (TPE vs ABC) and settings (ABC: 30, 50, and 70 W; TPE: Cut 10U, 20U, and 30U and Coagulation 10U, 20U, and 30U). Animals underwent necropsy with blinded histomorphologic evaluation on days 0, 3, and 10 postprocedure to assess for presence of bowel perforation, depth of thermal injury, and extent of inflammatory response. RESULTS: At necropsy, bowel perforation was not identified in any animals. Depth of treatment with ABC in the porcine colon was variable and unrelated to power settings whereas TPE was associated with a consistent treatment depth of 1.0 mm regardless of location or power. Treatment with ABC resulted in greater tissue coagulation and desiccation as well as increased rates of mucosal necrosis, especially at higher settings (>50 W). Treatment with TPE primarily resulted in tissue ablation and minimal mucosal necrosis at low settings (Coag 10U-20U). The inflammatory response associated with TPE treatments was interpreted as biologically benign, and less than that observed with the ABC regardless of treatment settings. CONCLUSIONS: Both ABC and TPE effectively ablate bowel serosa in a porcine model. The TPE seems to result in a more predictable tissue effect with less inflammatory response, especially when used at low power settings such as Coag 10U or 20U. These characteristics are appealing for ablation of bowel serosa implants during ovarian cancer surgery and warrant further investigation.
Subject(s)
Cytoreduction Surgical Procedures/instrumentation , Intestine, Small/surgery , Laser Coagulation/instrumentation , Laser Therapy/instrumentation , Plasma Gases/therapeutic use , Animals , Argon Plasma Coagulation/adverse effects , Argon Plasma Coagulation/instrumentation , Argon Plasma Coagulation/methods , Cytoreduction Surgical Procedures/adverse effects , Cytoreduction Surgical Procedures/methods , Female , Intestinal Mucosa/surgery , Laser Coagulation/adverse effects , Laser Therapy/adverse effects , Laser Therapy/methods , Models, Animal , SwineABSTRACT
OBJECTIVE: Electrically neutral argon plasma (PlasmaJet™) technology is a surgical option that helps to get an aggressive cytoreduction in selected patients with ovarian cancer because it can be directly applied by the surgeon to treat the tissue surface [1,2]. Upper abdominal surgical procedures are an important part of the surgery in these patients [3], there is a 22% complications rate when they are performed [4]. We present a surgical approach to ovarian cancer debulking using PlasmaJet™. METHODS: Case history and operative technique: 51 women supported for ovarian cancer Stage IIIC-IV were operated with systematic use of the PlasmaJet device at the Regional Institute Bergonié Cancer Center of Bordeaux, France between June 2012 and June 2014. 41.2% (n=21) patients underwent a Primary Debulking Surgery (PDS) and 58.8% (n=30) underwent an Interval Debulking Surgery. 78.4% (n=40) of the 51 patients studied had a complete cytoreduction. We present the case of a woman diagnosed with a mucinous ovarian carcinoma FIGO stage IVA, who underwent a PDS. Complete cytoreduction to no macroscopic disease was achieved, this included diaphragmatic and abdominal peritoneal stripping. RESULTS: No post-operative complications were found in this case. 15.7% (n=8) of patients undergoing diaphragmatic stripping with the PlasmaJet required a pleural drain. It is a safe structured procedure, which could be performed to achieve optimal surgical results for patients with ovarian cancer. CONCLUSIONS: PlasmaJet™ helps the surgeon to perform a peritoneal stripping of the upper abdominal areas and appears to enable the surgeon to remove more disease without increased morbidity, pushing the cytoreduction/morbidity tradeoff.
Subject(s)
Adenocarcinoma, Mucinous/surgery , Cytoreduction Surgical Procedures/methods , Diaphragm/surgery , Ovarian Neoplasms/surgery , Peritoneal Neoplasms/surgery , Adenocarcinoma, Mucinous/secondary , Argon Plasma Coagulation/instrumentation , Cytoreduction Surgical Procedures/instrumentation , Female , Humans , Neoplasm Staging , Ovarian Neoplasms/pathology , Peritoneal Neoplasms/secondaryABSTRACT
AIM: To estimate an efficacy of endoscopic treatment of benign cicatricial esophageal strictures using ionized argon plasma. MATERIAL AND METHODS: It is presented treatment of 35 patients with post-ambustial and 17 patients with peptic strictures of the esophagus. Their age ranged from 17 to 73 years. Esophageal stenosis achieved 0.1-1.0 cm. Local, tubular and prolonged stenoses were observed in 18 (51.5%), 3 (8.6%) and 14 (39.9%) patients respectively. Peptic stenoses were local in 100% of cases and localized in lower esophagus before cardia. RESULTS: Endoscopic techique resulted good and satisfactory outcomes in 53.8% and 27% of cases within short terms. The best results were obtained in case of local post-ambustial and peptic ulcers. At the end of treatment inflammation and mitotic activity were decreased in mucosa and submucosa of the narrowed segment. Also thickness of the epithelium and stratification of tissue layers were normal. Connective tissue volume was moderately decreased in subepithelial area.
Subject(s)
Argon Plasma Coagulation , Burns, Chemical/complications , Esophageal Stenosis , Esophagoscopy , Gastroesophageal Reflux/complications , Adult , Argon Plasma Coagulation/instrumentation , Argon Plasma Coagulation/methods , Biopsy , Esophageal Stenosis/diagnosis , Esophageal Stenosis/etiology , Esophageal Stenosis/surgery , Esophagoscopy/instrumentation , Esophagoscopy/methods , Esophagus/pathology , Female , Humans , Male , Middle Aged , Outcome and Process Assessment, Health CareABSTRACT
Benign prostatic hyperplasia (BPH) is one of the most common conditions affecting older men. Transurethral resection of the prostate (TURP) has widely been considered the gold standard in surgical treatment for BPH. However, this procedure remains largely an inpatient procedure. Inpatient admission ultimately adds to healthcare cost and patient morbidity. In this article, we present an alternative methodology to treat BPH using combination Olympus PlasmaButton and Olympus PlasmaLoop therapy. Preliminary results from our experience suggest improved hemostasis with adequate resection, allowing a majority of our patients to be discharged the same day of the procedure. We describe our novel technique as a safe and effective way to possibly treat BPH in an outpatient setting.
Subject(s)
Argon Plasma Coagulation , Hemostasis, Surgical , Patient Discharge/statistics & numerical data , Prostatic Hyperplasia , Surgical Instruments , Transurethral Resection of Prostate , Aged , Argon Plasma Coagulation/instrumentation , Argon Plasma Coagulation/methods , Hemostasis, Surgical/instrumentation , Hemostasis, Surgical/methods , Humans , Length of Stay/statistics & numerical data , Male , Middle Aged , Outcome and Process Assessment, Health Care , Prostate/pathology , Prostate/surgery , Prostatic Hyperplasia/diagnosis , Prostatic Hyperplasia/surgery , Transurethral Resection of Prostate/adverse effects , Transurethral Resection of Prostate/instrumentation , Transurethral Resection of Prostate/methodsABSTRACT
PURPOSE: The aim of this study was to compare the effect of panretinal photocoagulation for proliferative diabetic retinopathy (PDR) on diabetic macular edema (DME) using a Pascal® Photocoagulator (PP) or a conventional argon laser photocoagulator (CALP). METHODS: Eighty eyes with PDR and center-involving DME were randomized to PP or CALP. Both groups had baseline assessment of best-corrected visual acuity (BCVA) and were examined with optical coherence tomography and fluorescein angiography. RESULTS: The mean number of laser shots for the PP and CALP groups was 1,726.10 and 752.00 at session 1 and 1,589.00 and 830.00 (p < 0.001) at session 2, respectively. The mean central foveal thickness (CFT) at baseline was 306 ± 100 and 314 ± 98 for the PP and CALP groups, respectively. At 8 weeks, the mean CFT was 332 ± 116 and 347 ± 111 for the PP and CALP groups, respectively (p > 0.05). The mean BCVA was similar during the study period with no significant difference between the groups (p > 0.05). CONCLUSION: PP and CALP had similar effects on DME in PDR eyes and were equally safe with no significant increase in CFT.
Subject(s)
Diabetic Retinopathy/surgery , Laser Coagulation/instrumentation , Macular Edema/surgery , Adult , Argon Plasma Coagulation/instrumentation , Diabetic Retinopathy/physiopathology , Female , Fluorescein Angiography , Humans , Macular Edema/physiopathology , Male , Middle Aged , Prospective Studies , Tomography, Optical Coherence , Visual Acuity/physiology , Young AdultABSTRACT
BACKGROUND AND OBJECTIVES: Novel concepts to limit the spread of multidrug-resistant bacteria (MDR) are urgently needed. Since treatment with cold atmospheric plasma (CAP) has shown significant antibacterial properties, the purpose of this study was to evaluate the ability of CAP to eliminate MDR- compared to non-MDR-pathogens in chronic wounds. METHODS: Eleven patients with 18 heavily colonized wounds were treated with a CE-certified commercial argon-based CAP source for 10 s/cm(2) in one session. The antimicrobial efficacy was assessed by calculating the microbial load before and after treatment. RESULTS: A single CAP treatment reduced MDR in all wounds. In 14 treatments (63.6 %) and for 16 pathogens (66.7 %), a 100 % reduction of the bacterial load was observed. For 11 of 17 (64.7 %) MDR-pathogens and for 5 of 7 (71.4 %) other non-MDR-pathogens, complete eradication was achieved. The remaining 8 treatments showed reductions of 77.5 ± 18.6 % and the remaining pathogens a reduction of 74.8 ± 25.7 %. CONCLUSIONS: As proof of principle, argon-based CAP serves as a potent treatment modality that was shown to limit MDR microbial colonization. The possible role of CAP in clinical MDR decontamination must be evaluated in clinical trials with repeated plasma treatment embedded in a comprehensive hygienic decontamination concept.
Subject(s)
Argon Plasma Coagulation/instrumentation , Argon Plasma Coagulation/methods , Bacterial Infections/therapy , Disinfection/methods , Drug Resistance, Multiple, Bacterial , Wound Infection/therapy , Bacterial Infections/microbiology , Bacterial Load , Colony-Forming Units Assay , Equipment Design , Humans , Wound Infection/microbiologyABSTRACT
UNLABELLED: Aim of study was determination of effectiveness of endoscopic argon plasma coagulation and oxide of nitrogen in the treatment of Barretts esophagus. MATERIALS AND METHODS: Results of using argon plasma coagulation and oxide of nitrogen in the treatment of 26 patients with Barretts esophagus. RESULTS: It was shown that argon plasma coagulation is very effective and safe method for endoscopic treatment of Barretts esophagus. Ablation of short and long segment of Barretts esophagus is completed in all cases, but it requires follow up and biopsy. Oxide of nitrogen in the speed up process of epythelisation.
Subject(s)
Argon Plasma Coagulation/methods , Barrett Esophagus/diagnosis , Barrett Esophagus/therapy , Nitric Oxide/therapeutic use , Adolescent , Adult , Aged , Algorithms , Argon Plasma Coagulation/instrumentation , Barrett Esophagus/pathology , Biopsy , Endoscopy, Digestive System , Female , Humans , Male , Middle Aged , Nitric Oxide/administration & dosage , Treatment Outcome , Young AdultSubject(s)
Argon Plasma Coagulation/instrumentation , Proctitis/surgery , Radiation Injuries/surgery , Aged , Humans , Laser Coagulation , MaleABSTRACT
BACKGROUND: Surgical energy-based devices emit energy, which can interfere with other electronic devices (eg, implanted cardiac pacemakers and/or defibrillators). The purpose of this study was to quantify the amount of unintentional energy (electromagnetic interference [EMI]) transferred to an implanted cardiac defibrillator by common surgical energy-based devices. METHODS: A transvenous cardiac defibrillator was implanted in an anesthetized pig. The primary outcome measure was the average maximum EMI occurring on the implanted cardiac device during activations of multiple different surgical energy-based devices. RESULTS: The EMI transferred to the implanted cardiac device is as follows: traditional bipolar 30 W .01 ± .004 mV, advanced bipolar .004 ± .003 mV, ultrasonic shears .01 ± .004 mV, monopolar Bovie 30 W coagulation .50 ± .20 mV, monopolar Bovie 30 W blend .92 ± .63 mV, monopolar instrument without dispersive electrode .21 ± .07 mV, plasma energy 3.48 ± .78 mV, and argon beam coagulator 2.58 ± .34 mV. CONCLUSION: Surgeons can minimize EMI on implanted cardiac defibrillators by preferentially utilizing bipolar and ultrasonic devices.
Subject(s)
Argon Plasma Coagulation/instrumentation , Defibrillators, Implantable , Electromagnetic Phenomena , Electrosurgery/instrumentation , Ultrasonics/instrumentation , Animals , Radio Waves , SwineABSTRACT
Hemorrhagic radiation cystitis is an example of a typical radiotherapy-induced adverse event. However, the optimal treatment for hemorrhagic radiation cystitis is not known. There are limited data regarding the use of argon plasma coagulation for hemorrhagic radiation cystitis. Here, we present the use of argon plasma coagulation using a gastrointestinal endoscope to treat hemorrhagic radiation cystitis. The patient was a 75-year-old male patient with hemorrhagic radiation cystitis due to external beam irradiation for prostate adenocarcinoma. Six years after radiotherapy, the patient presented with macroscopic hematuria over the preceding 4 months, and laboratory investigations revealed a low hemoglobin level. The hematuria was not controlled with 2 days of bladder irrigation using normal saline. Thus, argon plasma coagulation using an upper gastrointestinal endoscope was considered for treatment of the hemorrhagic radiation cystitis. The cystoscopic examination revealed diffuse radiation cystitis with oozing telangiectasia and coagula. All of the bleeding sites and telangiectasia were coagulated using argon plasma coagulation. Following treatment, the patient's clinical symptoms improved and did not recur. The hemoglobin level also recovered. No complications associated with the treatment were observed during the 6-month follow-up period. Thus, argon plasma coagulation using a gastrointestinal endoscope is a safe and effective treatment for hemorrhagic radiation cystitis.
Subject(s)
Adenocarcinoma/radiotherapy , Argon Plasma Coagulation/instrumentation , Cystitis/etiology , Cystitis/therapy , Endoscopes, Gastrointestinal , Hematuria/etiology , Hematuria/therapy , Prostatic Neoplasms/radiotherapy , Radiation Injuries/therapy , Aged , Humans , Male , Radiation Injuries/etiology , Radiotherapy/adverse effects , Treatment OutcomeABSTRACT
BACKGROUND: This evaluation was undertaken to determine the incidence of bacteremia and infectious complications associated with argon plasma coagulation (APC) procedures. METHODS: Consecutive patients undergoing bronchoscopy with APC for treatment of endobronchial lesions were studied. Venesection was performed for blood cultures within 60 s of the APC procedure. APC catheter washings were cultured. Patients with positive blood cultures were reviewed immediately. All patients underwent clinical review 1 and 12 weeks after APC. RESULTS: Forty-two patients underwent 44 APC procedures. Their mean age was 66 ± 12 years. One case (2.3 %) had bacteremia with Acinetobacter lwolfii. APC catheter washing culture was positive in 14 (31.8 %) procedures. No patient had clinical features suggesting infection and there were no complications. Phone review after 1 week revealed no complications. After 3 months, 8 (18 %) had died, all related to advanced lung malignancy and not to the APC procedure. CONCLUSIONS: APC does not appear to increase the risk of bacteremia compared to airway insertion of the bronchoscope. Although contamination of the APC catheter with oropharyngeal commensal bacteria is common, clinically significant infection following the APC procedure is rare.
Subject(s)
Argon Plasma Coagulation/adverse effects , Bacteremia/epidemiology , Bronchoscopy/adverse effects , Catheter-Related Infections/epidemiology , Lung Neoplasms/therapy , Oropharynx/microbiology , Aged , Argon Plasma Coagulation/instrumentation , Bacteremia/diagnosis , Bacteremia/microbiology , Bronchoscopes , Bronchoscopy/instrumentation , Catheter-Related Infections/diagnosis , Catheter-Related Infections/microbiology , Catheters , Female , Humans , Incidence , Israel/epidemiology , Lung Neoplasms/pathology , Male , Middle Aged , Palliative Care , Pilot Projects , Prospective Studies , Time FactorsABSTRACT
Introduction: In severe cases refractory to medical treatment, APC appears to be the preferred alternative to control persistent rectal bleeding of patients with chronic radiation proctitis. Although successful outcomes have been demonstrated in patients previously treated with moderate doses of radiotherapy, there is reluctance towards its indication due to the concern of severe adverse events in patients treated with high doses of radiation. Objectives: The aim of this study was to assess the efficacy and toxicity of APC in the management of bleeding radiationinduced proctitis in patients treated with high doses of radiation for prostate cancer. Methods and materials: Data from 30 patients were treated with APC due to chronic radiation proctitis, were reviewed retrospectively. All cases had prostate cancer and 9 of them (30 %) underwent previous radical prostatectomy. The median dose of conformal 3D External Beam Radiotherapy (EBRT) delivered was 74 Gy (range 46-76). Median rectal D1cc and D2cc was 72.5 and 72.4 Gy respectively. Median rectal V70, V60 and V40 was 12, 39.5 and 80 %. Cardiovascular and digestive disease, diabetes, smoking behaviour, lowest haemoglobin and transfusion requirements were recorded. Indications for treatment with APC were anemia and persistent bleeding despite medical treatment. Argon gas flow was set at 1.8 l/min with an electrical power setting of 50 W. Results: Median age of all patients was 69.6 years. The median lowest haemoglobin level was 9.6 g/dL. Median time between completion of radiotherapy and first session of APC as 13 months. Ninety-four therapeutic sessions were performed (median 3 sessions). Median time follow-up was 14.5 months (range 2-61). Complete response with resolved rectal bleeding was achieved in 23 patients (77 %), partial response in 5 (16 %) and no control in 2 (6 %). No patients required transfusion following therapy. Two patients developed long-term (> 6 weeks) grade 2 rectal ulceration and grade 2 rectal incontinence, respectively. Conclusions: The argon plasma coagulation is an effective and safe management option in patients with medically refractory rectal bleeding after high doses of radiation for prostate cancer (AU)
No disponible
Subject(s)
Humans , Male , Middle Aged , Argon/therapeutic use , Proctitis/radiotherapy , Prostatic Neoplasms/radiotherapy , Prostatectomy/methods , Hemorrhage/complications , Hemorrhage/diagnosis , Risk Factors , Argon Plasma Coagulation/methods , Argon Plasma Coagulation , Treatment Outcome , Retrospective Studies , Argon/adverse effects , Argon/toxicity , Rectal Diseases/blood , Rectal Diseases/complications , Argon Plasma Coagulation/instrumentation , Argon Plasma Coagulation/trendsABSTRACT
We present 19 cases in which argon plasma coagulation (APC) was used as curative initial treatment for 5 low-grade esophageal squamous intraepithelial neoplasias (ESINs), 12 high-grade ESINs, and 2 early esophageal squamous cell carcinomas (ESCCs). Complete response was defined as the absence of tumor from any biopsy taken from the ablated lesion. At follow-up endoscopy 2 - 4 months after APC, 94.7 % of patients had achieved complete response in a single treatment session. Only one patient with high-grade ESIN showed local recurrence. This patient underwent additional APC and showed complete response at 12 months after initial APC. At the 12-month follow-up endoscopy, again 94.7 % had a complete response. The exception was one patient with local recurrence, who underwent additional APC. After the 12-month follow-up endoscopy, no patient showed local recurrence during a median follow-up of 22 months. No stricture requiring endoscopic dilation occurred after the procedure. This study suggests that APC is a feasible and effective treatment modality for ESIN and early ESCC.